Prevalence, incidence and duration of Braak's stages in the general population: can we know?
Duyckaerts
C
C
Laboratoire de Neuropathologie R. Escourolle, Association Claude Bernard, Inserm U 360, Hôpital de La Salpêtrière, Paris, France.
Hauw
J J
JJ
D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000473:pathology*; D016229:Amyloid beta-Peptides / Q000032:analysis; D001927:Brain Diseases / Q000175:diagnosis / Q000453:epidemiology* / Q000473:pathology; D002540:Cerebral Cortex / Q000737:chemistry / Q000473:pathology; D003704:Dementia / Q000175:diagnosis / Q000453:epidemiology / Q000473:pathology; D018450:Disease Progression; D006801:Humans; D015994:Incidence; D008875:Middle Aged; D016874:Neurofibrillary Tangles / Q000737:chemistry / Q000473:pathology*; D058225:Plaque, Amyloid / Q000737:chemistry / Q000473:pathology*; D015995:Prevalence; D012107:Research Design
D016229:Amyloid beta-Peptides